Colgate-Palmolive (NYSE:CL – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Raymond ...

Cullinan Associates Inc. cut its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 7.9% in the 4th quarter, ...

Colgate-Palmolive (NYSE:CL – Free Report) had its price objective trimmed by JPMorgan Chase & Co. from $103.00 to $97.00 in a ...

Colgate-Palmolive (NYSE:CL), a global leader in consumer products, has demonstrated resilience in the face of economic headwinds and market volatility. The company's strong brand portfolio and ...

Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...

In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...

We recently published an article titled Jim Cramer Discusses These 10 Stocks & DeepSeek’s Limitations. In this article, we ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line ...

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

CL's Q4 results show continued gains from volume and pricing, leading to organic sales growth in five of the six divisions.

Colgate announced the re-launch of Colgate Total in 2025, featuring upgraded offerings in toothpaste, manual toothbrushes, and mouthwash. Investments in data, analytics, and AI are expected to support ...

Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.